Live news related to EUROFINS SCIENT. stock (FR0014000MR3): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on EUROFINS SCIENT. mainly cover analyst notes, M&A activity et guidance and outlook. The stock trades at €73,34 on Euronext Paris, up 1,64% at the last update. This page lists the articles published on EUROFINS SCIENT. stock to track the share price, company announcements and any item likely to influence market perception.
After slipping below €72 last week, Eurofins Scientific regains momentum this Monday and ranks among the strongest gains in the CAC 40, while the inde…
Eurofins Scientific declines during Monday's session, even as the CAC 40 resists slightly in positive territory. The stock falls back below €72, erasi…
While the CAC 40 loses ground during the session, Eurofins Scientific stands out and ranks among the strongest gainers of the index. The group special…
The Luxembourg-based bioanalytical testing specialist loses ground in the Paris session, moving against a slightly bullish CAC 40. The decline occurs …
The Luxembourg-based bioanalytical testing specialist significantly advances in late Paris trading, erasing the previous day's decline. The stock is a…
The Luxembourg-based bioanalytical testing specialist significantly falls mid-session, against its recent momentum. The decline is part of a heavily p…
Eurobio Scientific has finalized the acquisition of CareDx's Lab Products division for 145 million euros, approximately 170 million dollars. This tran…
The Luxembourg-based bioanalytical testing specialist marks another session of gains in Paris. The stock continues the momentum started the previous d…
The Luxembourg-based bioanalytical testing specialist stands out at midday in a sharply retreating CAC 40. The stock benefits from a favorable rotatio…
The Luxembourg-based bioanalytical testing specialist registers a sharp rebound during the session, supported by a well-oriented CAC 40. The stock cro…
